National HealthCare Corporation (NHC) 10-Year Financial Performance & Capital Metrics

NHC •

HealthcareHealthcare FacilitiesPost-acute and senior care

AboutNational HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and a behavioral health hospital. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living centers offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. It also offers behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, it provides health care programs that offer skilled services, such as infusion, wound care and physical, occupational, and speech therapies; hospice care services; operates pharmacies; offers management, accounting, financial, and insurance services; and leases its properties to third party operators. As of February 18, 2022, the company operated 75 skilled nursing facilities with 9,473 beds, 24 assisted living facilities, five independent living facilities, one behavioral health hospital, 34 homecare agencies, and 28 hospice agencies. National HealthCare Corporation was founded in 1971 and is based in Murfreesboro, Tennessee.Show more

Revenue $1.47B +13.2%
EBITDA $173M +35.6%
Net Income $120M +17.7%
EPS (Diluted) 7.67 +17.5%
Gross Margin 37.33% -0.5%
EBITDA Margin 11.79% +19.8%
Operating Margin 8.73% +32.2%
Net Margin 8.17% +4.0%
ROE 11.67% +8.4%
ROIC 8.43% +32.3%
Debt/Equity 0.08 -62.9%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Strong 5Y profit CAGR of 23.4%
✓12 consecutive years of dividend growth
✓Momentum leader: RS Rating 84 (top 16%)
✓High quality earnings: Operating CF exceeds net income
✓Trading near 52-week high

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y4.95%

5Y8.43%

3Y11.01%

TTM22.05%

Profit (Net Income) CAGR

10Y8.49%

5Y23.44%

3Y74.87%

TTM-18.51%

EPS CAGR

10Y9.14%

5Y23.04%

3Y74.24%

TTM-18.8%

ROCE

10Y Avg5.6%

5Y Avg5.67%

3Y Avg6.96%

Latest8.43%

Peer Comparison

Post-acute and senior care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PNTGThe Pennant Group, Inc.	1.18B	33.71	40.13	36.31%	3.12%	7.9%	4.11%	1.21
ENSGThe Ensign Group, Inc.	12.4B	214.17	36.67	18.72%	6.8%	15.46%	2.99%	0.93
NHCNational HealthCare Corporation	2.54B	163.50	21.32	13.23%	6.75%	9.57%	5.86%	0.08
EHCEncompass Health Corporation	10.79B	107.88	19.44	10.46%	9.33%	16.98%		0.08
SEMSelect Medical Holdings Corporation	1.85B	14.97	12.91	5.12%	2.8%	5.47%	20.65%	0.51
BKDBrookdale Senior Living Inc.	3.64B	15.30	-13.66	7.29%	-8.21%	-308.45%	5.99%
SNDASonida Senior Living, Inc.	681.62M	35.89	-66.46	19.19%	-12.39%	-53.82%		5.03

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	923.58M	963.89M	980.35M	996.38M	980.71M	1.01B	1.07B	1.14B	1.3B	1.47B
Revenue Growth %	1.87%	4.37%	1.71%	1.64%	-1.57%	3.08%	6.27%	6.26%	13.7%	13.23%
Cost of Goods Sold+	548.01M	572.04M	582.72M	592.83M	609.31M	666.06M	686.17M	712.34M	810.93M	921.08M
COGS % of Revenue	59.34%	59.35%	59.44%	59.5%	62.13%	65.89%	63.87%	62.4%	62.48%	62.67%
Gross Profit+	375.57M	391.85M	397.63M	403.55M	371.41M	344.88M	388.11M	429.2M	487.01M	548.55M
Gross Margin %	40.66%	40.65%	40.56%	40.5%	37.87%	34.11%	36.13%	37.6%	37.52%	37.33%
Gross Profit Growth %	0.45%	4.33%	1.47%	1.49%	-7.97%	-7.14%	12.54%	10.59%	13.47%	12.64%
Operating Expenses+	315.03M	337.74M	341.55M	354.51M	323.25M	293.95M	356.22M	372.07M	401.25M	468.35M
OpEx % of Revenue	34.11%	35.04%	34.84%	35.58%	32.96%	29.08%	33.16%	32.59%	30.91%	31.87%
Selling, General & Admin	41.29M	40.37M	40.92M	40.52M	40.49M	40.82M	40.98M	41.52M	43.18M	0
SG&A % of Revenue	4.47%	4.19%	4.17%	4.07%	4.13%	4.04%	3.81%	3.64%	3.33%	-
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	273.74M	297.38M	300.63M	314M	282.76M	253.14M	315.24M	330.54M	358.06M	468.35M
Operating Income+	60.54M	54.11M	56.08M	49.04M	48.16M	50.92M	31.9M	57.13M	85.76M	128.35M
Operating Margin %	6.56%	5.61%	5.72%	4.92%	4.91%	5.04%	2.97%	5%	6.61%	8.73%
Operating Income Growth %	-9.81%	-10.62%	3.63%	-12.55%	-1.8%	5.75%	-37.37%	79.13%	50.1%	49.66%
EBITDA+	99.56M	96.76M	97.97M	91.46M	90.17M	91.6M	72.39M	99.17M	127.75M	173.27M
EBITDA Margin %	10.78%	10.04%	9.99%	9.18%	9.19%	9.06%	6.74%	8.69%	9.84%	11.79%
EBITDA Growth %	-4.48%	-2.82%	1.25%	-6.65%	-1.4%	1.58%	-20.97%	37%	28.82%	35.64%
D&A (Non-Cash Add-back)	39.02M	42.65M	41.89M	42.42M	42.02M	40.67M	40.49M	42.03M	41.98M	44.92M
EBIT	84.15M	79.44M	79.58M	91.15M	53.82M	150.88M	27.79M	89.06M	140.54M	0
Net Interest Income+	1.54M	1.28M	2.49M	4.05M	4.4M	3.82M	4.57M	8.06M	5.97M	0
Interest Income	5.48M	6.17M	7.18M	7.19M	5.79M	4.67M	5.13M	8.38M	10.1M	0
Interest Expense	3.94M	4.89M	4.7M	3.13M	1.4M	845K	563K	324K	4.13M	-6.37M
Other Income/Expense	19.66M	20.44M	18.81M	38.98M	4.27M	99.11M	-4.67M	31.6M	50.65M	34.08M
Pretax Income+	80.21M	74.55M	74.88M	88.02M	52.42M	150.04M	27.23M	88.74M	136.41M	162.43M
Pretax Margin %	8.68%	7.73%	7.64%	8.83%	5.35%	14.84%	2.53%	7.77%	10.51%	11.05%
Income Tax+	29.67M	18.87M	16.18M	20.04M	10.43M	10.95M	7.25M	23.45M	34.32M	-39.83M
Effective Tax Rate %	63.01%	75.39%	78.74%	77.5%	79.87%	92.37%	82.42%	75.28%	74.72%	73.89%
Net Income+	50.54M	56.2M	58.96M	68.21M	41.87M	138.59M	22.45M	66.8M	101.93M	120.02M
Net Margin %	5.47%	5.83%	6.01%	6.85%	4.27%	13.71%	2.09%	5.85%	7.85%	8.17%
Net Income Growth %	-4.9%	11.21%	4.91%	15.68%	-38.62%	230.99%	-83.8%	197.61%	52.59%	17.75%
Net Income (Continuing)	50.54M	55.68M	58.7M	67.98M	41.99M	139.09M	19.98M	65.29M	102.09M	120.02M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	-40.02M	694K	1.18M	476K	3.08M	5.46M	3.24M	1.73M	3M	5.74M
EPS (Diluted)+	3.32	3.69	3.87	4.44	2.72	8.99	1.45	4.34	6.53	7.67
EPS Growth %	3.75%	11.14%	4.88%	14.73%	-38.74%	230.51%	-83.87%	199.31%	50.46%	17.46%
EPS (Basic)	3.34	3.70	3.87	4.47	2.74	9.03	1.46	4.36	6.62	7.76
Diluted Shares Outstanding	15.21M	15.22M	15.24M	15.36M	15.37M	15.42M	15.45M	15.38M	15.6M	15.65M
Basic Shares Outstanding	15.13M	15.19M	15.22M	15.27M	15.31M	15.35M	15.41M	15.31M	15.39M	15.47M
Dividend Payout Ratio	51.04%	50.24%	50.59%	45.75%	76.24%	23.11%	154.17%	53.24%	36.27%	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	290.86M	329.31M	322.01M	341.05M	456.75M	426.64M	353.93M	406.24M	424.41M	0
Cash & Short-Term Investments	164.35M	198.2M	183.47M	202.79M	323.44M	256.02M	182.59M	223.62M	216.19M	0
Cash Only	26.34M	198.2M	183.47M	50.33M	147.09M	107.61M	58.67M	107.08M	76.12M	0
Short-Term Investments	164.35M	0	0	152.45M	176.35M	148.42M	123.92M	116.54M	140.06M	0
Accounts Receivable	80.76M	93.68M	98.56M	91.32M	89.67M	96.58M	100.29M	109.05M	135.84M	0
Days Sales Outstanding	31.91	35.47	36.7	33.45	33.37	34.87	34.07	34.87	38.2	-
Inventory	7.51M	7.15M	7.47M	7.44M	8.78M	8.58M	7.09M	7.39M	9.04M	0
Days Inventory Outstanding	5	4.56	4.68	4.58	5.26	4.7	3.77	3.78	4.07	-
Other Current Assets	35.6M	27.41M	28.64M	32.87M	30.95M	58.09M	63.97M	66.18M	63.35M	0
Total Non-Current Assets+	796.59M	767.22M	758.94M	945.6M	905.38M	976.76M	921.52M	904.56M	1.1B	0
Property, Plant & Equipment	559.62M	549.32M	534.65M	738.34M	699.37M	677.11M	627.05M	587.53M	763.46M	0
Fixed Asset Turnover	1.65x	1.75x	1.83x	1.35x	1.40x	1.49x	1.71x	1.94x	1.70x	-
Goodwill	17.6M	17.6M	21M	21M	21.34M	168.29M	168.29M	168.29M	170.48M	0
Intangible Assets	0	0	0	0	0	7.04M	7.04M	7.04M	19.86M	0
Long-Term Investments	37.24M	36.34M	32.36M	39.19M	40.78M	2.02M	2.06M	16.27M	27.88M	0
Other Non-Current Assets	160.05M	145.58M	152.38M	147.07M	143.88M	122.29M	117.07M	125.43M	118.34M	0
Total Assets+	1.09B	1.1B	1.08B	1.29B	1.36B	1.4B	1.28B	1.31B	1.52B	0
Asset Turnover	0.85x	0.88x	0.91x	0.77x	0.72x	0.72x	0.84x	0.87x	0.85x	-
Asset Growth %	4.03%	0.83%	-1.42%	19.03%	5.87%	3.03%	-9.12%	2.77%	16.3%	-100%
Total Current Liabilities+	150.93M	155.06M	157.92M	194.76M	281.23M	263.2M	197.89M	214.48M	234.8M	253.63M
Accounts Payable	18.59M	15.98M	19.76M	18.9M	21.11M	22.49M	16.96M	19.19M	25.49M	22.77M
Days Payables Outstanding	12.38	10.2	12.38	11.64	12.65	12.32	9.02	9.83	11.47	9.02
Short-Term Debt	3.48M	3.7M	3.92M	10M	0	0	0	0	7.5M	41.11M
Deferred Revenue (Current)	3.36M	3.23M	3.05M	0	67.32M	24.46M	0	0	0	0
Other Current Liabilities	35.62M	39.91M	38.97M	15.03M	21.34M	20.06M	17.61M	22.99M	21.38M	212.52M
Current Ratio	1.93x	2.12x	2.04x	1.75x	1.62x	1.62x	1.79x	1.89x	1.81x	-
Quick Ratio	1.88x	2.08x	1.99x	1.71x	1.59x	1.59x	1.75x	1.86x	1.77x	-
Cash Conversion Cycle	24.53	29.84	29	26.4	25.99	27.25	28.82	28.82	30.79	-
Total Non-Current Liabilities+	266.91M	238.72M	189.75M	312.82M	282.64M	231.74M	200.05M	185.84M	306.47M	198.27M
Long-Term Debt	120M	100M	55M	0	0	0	0	0	129.5M	45.96M
Capital Lease Obligations	26.75M	23.05M	19.13M	193.63M	164.14M	134.39M	91.88M	63.17M	45.92M	0
Deferred Tax Liabilities	22.07M	18.38M	18.55M	24.01M	14.08M	6.85M	10.91M	17.2M	35.55M	42.69M
Other Non-Current Liabilities	91.49M	114.98M	114.44M	90M	104.42M	90.5M	97.26M	105.47M	95.49M	109.62M
Total Liabilities	417.84M	393.79M	347.67M	507.58M	563.87M	494.94M	397.94M	400.32M	541.27M	451.9M
Total Debt+	150.23M	126.75M	78.05M	232.04M	194.02M	166.66M	125.94M	93.39M	214.77M	87.07M
Net Debt	123.89M	-71.45M	-105.42M	181.7M	46.92M	59.05M	67.27M	-13.69M	138.65M	87.07M
Debt / Equity	0.24x	0.18x	0.11x	0.30x	0.24x	0.18x	0.14x	0.10x	0.22x	0.08x
Debt / EBITDA	1.51x	1.31x	0.80x	2.54x	2.15x	1.82x	1.74x	0.94x	1.68x	0.50x
Net Debt / EBITDA	1.24x	-0.74x	-1.08x	1.99x	0.52x	0.64x	0.93x	-0.14x	1.09x	0.50x
Interest Coverage	15.36x	11.07x	11.94x	15.64x	34.42x	60.27x	56.65x	176.34x	20.74x	-
Total Equity+	629.59M	703.43M	734.46M	779.07M	798.26M	908.46M	877.51M	910.48M	983.16M	1.07B
Equity Growth %	-0.22%	11.73%	4.41%	6.07%	2.46%	13.8%	-3.41%	3.76%	7.98%	9.29%
Book Value per Share	41.40	46.22	48.20	50.72	51.94	58.93	56.81	59.21	63.03	68.68
Total Shareholders' Equity	669.61M	702.74M	733.28M	778.59M	795.18M	903M	874.28M	908.75M	980.16M	1.07B
Common Stock	152K	152K	153K	153K	153K	154K	153K	153K	154K	155K
Retained Earnings	391.93M	419.42M	516.43M	553.09M	563.02M	669.08M	656.66M	687.6M	752.19M	832.98M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	66.07M	67.5M	-2.75M	2.56M	5.06M	1.6M	-9.53M	-6.6M	-4.72M	-779K
Minority Interest	-40.02M	694K	1.18M	476K	3.08M	5.46M	3.24M	1.73M	3M	5.74M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	90.88M	94.47M	98.44M	100.1M	203.26M	62.39M	8.74M	111.22M	107.3M	185.08M
Operating CF Margin %	9.84%	9.8%	10.04%	10.05%	20.73%	6.17%	0.81%	9.74%	8.27%	12.59%
Operating CF Growth %	22.88%	3.94%	4.2%	1.69%	103.05%	-69.3%	-85.99%	1172.2%	-3.52%	72.48%
Net Income	50.54M	55.68M	58.7M	67.98M	41.99M	139.09M	19.98M	65.29M	102.09M	122.61M
Depreciation & Amortization	39.02M	42.65M	41.89M	42.42M	42.02M	40.67M	40.49M	42.03M	41.98M	44.92M
Stock-Based Compensation	509K	1.68M	1.78M	1.88M	2.45M	2.62M	2.61M	2.78M	4.16M	4.4M
Deferred Taxes	4.79M	-4.71M	718K	4.05M	-10.59M	-6.29M	6M	5.77M	17.94M	6.48M
Other Non-Cash Items	6.57M	5.89M	-653K	-20.17M	16.99M	-72.95M	13.37M	-22.05M	-33.15M	6.68M
Working Capital Changes	-10.55M	-6.72M	-4M	3.95M	110.4M	-40.74M	-73.7M	17.4M	-25.72M	0
Change in Receivables	-4.4M	-9.49M	-9.4M	4.3M	4.53M	4.09M	-3.86M	-8.56M	-26.44M	-3.68M
Change in Inventory	60K	355K	-317K	29K	-1.25M	199K	1.49M	-298K	-599K	1.24M
Change in Payables	-1.53M	-2.62M	3.47M	-856K	1.43M	-2.08M	-5.53M	2.24M	6.3M	-2.73M
Cash from Investing+	-81.48M	-9.56M	-33.66M	-14.27M	-63.88M	-65.89M	-5.98M	-17.57M	-236.69M	-33.86M
Capital Expenditures	-62.6M	-32.35M	-29.77M	-26.4M	-21.87M	-39.4M	-30.2M	-27.9M	-27.6M	-36.45M
CapEx % of Revenue	6.78%	3.36%	3.04%	2.65%	2.23%	3.9%	2.81%	2.44%	2.13%	2.48%
Acquisitions	-1.28M	-246K	3.33M	-15.81M	-203K	-29.06M	0	-7.36M	-228.1M	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-3.62M	4.08M	1.55M	-4.08M	2.06M	8.84M	8.05M	-201K	2.09M	-3.95M
Cash from Financing+	-27.13M	-49.07M	-77.27M	-79.75M	-41.89M	-35.26M	-47.64M	-42.55M	100.34M	-135.96M
Debt Issued (Net)	-3.28M	-23.48M	-48.7M	-48.92M	-14.17M	-4.42M	-4.7M	-4.99M	136.14M	0
Equity Issued (Net)	1000K	1000K	1000K	1000K	1000K	1000K	-1000K	-1000K	766K	0
Dividends Paid	-25.8M	-28.24M	-29.83M	-31.21M	-31.92M	-32.03M	-34.6M	-35.56M	-36.96M	-38.7M
Share Repurchases	-8.2M	0	-867K	-872K	-53K	-836K	-9.9M	-2.48M	-13.5M	-14.73M
Other Financing	-635K	120K	-749K	-1.09M	2.5M	-1.42M	-554K	169K	402K	-97.25M
Net Change in Cash	-17.73M	35.83M	-12.5M	6.09M	97.49M	-38.76M	-44.88M	51.1M	-29.05M	15.27M
Free Cash Flow+	28.28M	62.12M	68.66M	73.7M	181.39M	23M	-21.46M	83.31M	79.7M	148.63M
FCF Margin %	3.06%	6.44%	7%	7.4%	18.5%	2.27%	-2%	7.3%	6.14%	10.11%
FCF Growth %	81.91%	119.65%	10.53%	7.34%	146.1%	-87.32%	-193.32%	488.27%	-4.34%	86.48%
FCF per Share	1.86	4.08	4.51	4.80	11.80	1.49	-1.39	5.42	5.11	9.50
FCF Conversion (FCF/Net Income)	1.80x	1.68x	1.67x	1.47x	4.85x	0.45x	0.39x	1.66x	1.05x	1.54x
Interest Paid	4.53M	5.18M	4.9M	3.12M	1.43M	845K	493K	290K	3.42M	0
Taxes Paid	27.67M	23.55M	9.18M	20.89M	16.52M	22.88M	8.77M	14.57M	17.52M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	8.02%	8.43%	8.2%	9.01%	5.31%	16.24%	2.51%	7.47%	10.77%	11.67%
Return on Invested Capital (ROIC)	6.06%	5.86%	6.67%	4.63%	4%	4.21%	2.5%	4.65%	6.37%	8.43%
Gross Margin	40.66%	40.65%	40.56%	40.5%	37.87%	34.11%	36.13%	37.6%	37.52%	37.33%
Net Margin	5.47%	5.83%	6.01%	6.85%	4.27%	13.71%	2.09%	5.85%	7.85%	8.17%
Debt / Equity	0.24x	0.18x	0.11x	0.30x	0.24x	0.18x	0.14x	0.10x	0.22x	0.08x
Interest Coverage	15.36x	11.07x	11.94x	15.64x	34.42x	60.27x	56.65x	176.34x	20.74x	-
FCF Conversion	1.80x	1.68x	1.67x	1.47x	4.85x	0.45x	0.39x	1.66x	1.05x	1.54x
Revenue Growth	1.87%	4.37%	1.71%	1.64%	-1.57%	3.08%	6.27%	6.26%	13.7%	13.23%

US Stock Screener

...

National HealthCare Corporation (NHC) 10-Year Financial Performance & Capital Metrics

NHC •

HealthcareHealthcare FacilitiesPost-acute and senior care

Revenue $1.47B +13.2%
EBITDA $173M +35.6%
Net Income $120M +17.7%
EPS (Diluted) 7.67 +17.5%
Gross Margin 37.33% -0.5%
EBITDA Margin 11.79% +19.8%
Operating Margin 8.73% +32.2%
Net Margin 8.17% +4.0%
ROE 11.67% +8.4%
ROIC 8.43% +32.3%
Debt/Equity 0.08 -62.9%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Strong 5Y profit CAGR of 23.4%
✓12 consecutive years of dividend growth
✓Momentum leader: RS Rating 84 (top 16%)
✓High quality earnings: Operating CF exceeds net income
✓Trading near 52-week high

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y4.95%

5Y8.43%

3Y11.01%

TTM22.05%

Profit (Net Income) CAGR

10Y8.49%

5Y23.44%

3Y74.87%

TTM-18.51%

EPS CAGR

10Y9.14%

5Y23.04%

3Y74.24%

TTM-18.8%

ROCE

10Y Avg5.6%

5Y Avg5.67%

3Y Avg6.96%

Latest8.43%

Peer Comparison

Post-acute and senior care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PNTGThe Pennant Group, Inc.	1.18B	33.71	40.13	36.31%	3.12%	7.9%	4.11%	1.21
ENSGThe Ensign Group, Inc.	12.4B	214.17	36.67	18.72%	6.8%	15.46%	2.99%	0.93
NHCNational HealthCare Corporation	2.54B	163.50	21.32	13.23%	6.75%	9.57%	5.86%	0.08
EHCEncompass Health Corporation	10.79B	107.88	19.44	10.46%	9.33%	16.98%		0.08
SEMSelect Medical Holdings Corporation	1.85B	14.97	12.91	5.12%	2.8%	5.47%	20.65%	0.51
BKDBrookdale Senior Living Inc.	3.64B	15.30	-13.66	7.29%	-8.21%	-308.45%	5.99%
SNDASonida Senior Living, Inc.	681.62M	35.89	-66.46	19.19%	-12.39%	-53.82%		5.03

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	923.58M	963.89M	980.35M	996.38M	980.71M	1.01B	1.07B	1.14B	1.3B	1.47B
Revenue Growth %	1.87%	4.37%	1.71%	1.64%	-1.57%	3.08%	6.27%	6.26%	13.7%	13.23%
Cost of Goods Sold+	548.01M	572.04M	582.72M	592.83M	609.31M	666.06M	686.17M	712.34M	810.93M	921.08M
COGS % of Revenue	59.34%	59.35%	59.44%	59.5%	62.13%	65.89%	63.87%	62.4%	62.48%	62.67%
Gross Profit+	375.57M	391.85M	397.63M	403.55M	371.41M	344.88M	388.11M	429.2M	487.01M	548.55M
Gross Margin %	40.66%	40.65%	40.56%	40.5%	37.87%	34.11%	36.13%	37.6%	37.52%	37.33%
Gross Profit Growth %	0.45%	4.33%	1.47%	1.49%	-7.97%	-7.14%	12.54%	10.59%	13.47%	12.64%
Operating Expenses+	315.03M	337.74M	341.55M	354.51M	323.25M	293.95M	356.22M	372.07M	401.25M	468.35M
OpEx % of Revenue	34.11%	35.04%	34.84%	35.58%	32.96%	29.08%	33.16%	32.59%	30.91%	31.87%
Selling, General & Admin	41.29M	40.37M	40.92M	40.52M	40.49M	40.82M	40.98M	41.52M	43.18M	0
SG&A % of Revenue	4.47%	4.19%	4.17%	4.07%	4.13%	4.04%	3.81%	3.64%	3.33%	-
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	273.74M	297.38M	300.63M	314M	282.76M	253.14M	315.24M	330.54M	358.06M	468.35M
Operating Income+	60.54M	54.11M	56.08M	49.04M	48.16M	50.92M	31.9M	57.13M	85.76M	128.35M
Operating Margin %	6.56%	5.61%	5.72%	4.92%	4.91%	5.04%	2.97%	5%	6.61%	8.73%
Operating Income Growth %	-9.81%	-10.62%	3.63%	-12.55%	-1.8%	5.75%	-37.37%	79.13%	50.1%	49.66%
EBITDA+	99.56M	96.76M	97.97M	91.46M	90.17M	91.6M	72.39M	99.17M	127.75M	173.27M
EBITDA Margin %	10.78%	10.04%	9.99%	9.18%	9.19%	9.06%	6.74%	8.69%	9.84%	11.79%
EBITDA Growth %	-4.48%	-2.82%	1.25%	-6.65%	-1.4%	1.58%	-20.97%	37%	28.82%	35.64%
D&A (Non-Cash Add-back)	39.02M	42.65M	41.89M	42.42M	42.02M	40.67M	40.49M	42.03M	41.98M	44.92M
EBIT	84.15M	79.44M	79.58M	91.15M	53.82M	150.88M	27.79M	89.06M	140.54M	0
Net Interest Income+	1.54M	1.28M	2.49M	4.05M	4.4M	3.82M	4.57M	8.06M	5.97M	0
Interest Income	5.48M	6.17M	7.18M	7.19M	5.79M	4.67M	5.13M	8.38M	10.1M	0
Interest Expense	3.94M	4.89M	4.7M	3.13M	1.4M	845K	563K	324K	4.13M	-6.37M
Other Income/Expense	19.66M	20.44M	18.81M	38.98M	4.27M	99.11M	-4.67M	31.6M	50.65M	34.08M
Pretax Income+	80.21M	74.55M	74.88M	88.02M	52.42M	150.04M	27.23M	88.74M	136.41M	162.43M
Pretax Margin %	8.68%	7.73%	7.64%	8.83%	5.35%	14.84%	2.53%	7.77%	10.51%	11.05%
Income Tax+	29.67M	18.87M	16.18M	20.04M	10.43M	10.95M	7.25M	23.45M	34.32M	-39.83M
Effective Tax Rate %	63.01%	75.39%	78.74%	77.5%	79.87%	92.37%	82.42%	75.28%	74.72%	73.89%
Net Income+	50.54M	56.2M	58.96M	68.21M	41.87M	138.59M	22.45M	66.8M	101.93M	120.02M
Net Margin %	5.47%	5.83%	6.01%	6.85%	4.27%	13.71%	2.09%	5.85%	7.85%	8.17%
Net Income Growth %	-4.9%	11.21%	4.91%	15.68%	-38.62%	230.99%	-83.8%	197.61%	52.59%	17.75%
Net Income (Continuing)	50.54M	55.68M	58.7M	67.98M	41.99M	139.09M	19.98M	65.29M	102.09M	120.02M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	-40.02M	694K	1.18M	476K	3.08M	5.46M	3.24M	1.73M	3M	5.74M
EPS (Diluted)+	3.32	3.69	3.87	4.44	2.72	8.99	1.45	4.34	6.53	7.67
EPS Growth %	3.75%	11.14%	4.88%	14.73%	-38.74%	230.51%	-83.87%	199.31%	50.46%	17.46%
EPS (Basic)	3.34	3.70	3.87	4.47	2.74	9.03	1.46	4.36	6.62	7.76
Diluted Shares Outstanding	15.21M	15.22M	15.24M	15.36M	15.37M	15.42M	15.45M	15.38M	15.6M	15.65M
Basic Shares Outstanding	15.13M	15.19M	15.22M	15.27M	15.31M	15.35M	15.41M	15.31M	15.39M	15.47M
Dividend Payout Ratio	51.04%	50.24%	50.59%	45.75%	76.24%	23.11%	154.17%	53.24%	36.27%	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	290.86M	329.31M	322.01M	341.05M	456.75M	426.64M	353.93M	406.24M	424.41M	0
Cash & Short-Term Investments	164.35M	198.2M	183.47M	202.79M	323.44M	256.02M	182.59M	223.62M	216.19M	0
Cash Only	26.34M	198.2M	183.47M	50.33M	147.09M	107.61M	58.67M	107.08M	76.12M	0
Short-Term Investments	164.35M	0	0	152.45M	176.35M	148.42M	123.92M	116.54M	140.06M	0
Accounts Receivable	80.76M	93.68M	98.56M	91.32M	89.67M	96.58M	100.29M	109.05M	135.84M	0
Days Sales Outstanding	31.91	35.47	36.7	33.45	33.37	34.87	34.07	34.87	38.2	-
Inventory	7.51M	7.15M	7.47M	7.44M	8.78M	8.58M	7.09M	7.39M	9.04M	0
Days Inventory Outstanding	5	4.56	4.68	4.58	5.26	4.7	3.77	3.78	4.07	-
Other Current Assets	35.6M	27.41M	28.64M	32.87M	30.95M	58.09M	63.97M	66.18M	63.35M	0
Total Non-Current Assets+	796.59M	767.22M	758.94M	945.6M	905.38M	976.76M	921.52M	904.56M	1.1B	0
Property, Plant & Equipment	559.62M	549.32M	534.65M	738.34M	699.37M	677.11M	627.05M	587.53M	763.46M	0
Fixed Asset Turnover	1.65x	1.75x	1.83x	1.35x	1.40x	1.49x	1.71x	1.94x	1.70x	-
Goodwill	17.6M	17.6M	21M	21M	21.34M	168.29M	168.29M	168.29M	170.48M	0
Intangible Assets	0	0	0	0	0	7.04M	7.04M	7.04M	19.86M	0
Long-Term Investments	37.24M	36.34M	32.36M	39.19M	40.78M	2.02M	2.06M	16.27M	27.88M	0
Other Non-Current Assets	160.05M	145.58M	152.38M	147.07M	143.88M	122.29M	117.07M	125.43M	118.34M	0
Total Assets+	1.09B	1.1B	1.08B	1.29B	1.36B	1.4B	1.28B	1.31B	1.52B	0
Asset Turnover	0.85x	0.88x	0.91x	0.77x	0.72x	0.72x	0.84x	0.87x	0.85x	-
Asset Growth %	4.03%	0.83%	-1.42%	19.03%	5.87%	3.03%	-9.12%	2.77%	16.3%	-100%
Total Current Liabilities+	150.93M	155.06M	157.92M	194.76M	281.23M	263.2M	197.89M	214.48M	234.8M	253.63M
Accounts Payable	18.59M	15.98M	19.76M	18.9M	21.11M	22.49M	16.96M	19.19M	25.49M	22.77M
Days Payables Outstanding	12.38	10.2	12.38	11.64	12.65	12.32	9.02	9.83	11.47	9.02
Short-Term Debt	3.48M	3.7M	3.92M	10M	0	0	0	0	7.5M	41.11M
Deferred Revenue (Current)	3.36M	3.23M	3.05M	0	67.32M	24.46M	0	0	0	0
Other Current Liabilities	35.62M	39.91M	38.97M	15.03M	21.34M	20.06M	17.61M	22.99M	21.38M	212.52M
Current Ratio	1.93x	2.12x	2.04x	1.75x	1.62x	1.62x	1.79x	1.89x	1.81x	-
Quick Ratio	1.88x	2.08x	1.99x	1.71x	1.59x	1.59x	1.75x	1.86x	1.77x	-
Cash Conversion Cycle	24.53	29.84	29	26.4	25.99	27.25	28.82	28.82	30.79	-
Total Non-Current Liabilities+	266.91M	238.72M	189.75M	312.82M	282.64M	231.74M	200.05M	185.84M	306.47M	198.27M
Long-Term Debt	120M	100M	55M	0	0	0	0	0	129.5M	45.96M
Capital Lease Obligations	26.75M	23.05M	19.13M	193.63M	164.14M	134.39M	91.88M	63.17M	45.92M	0
Deferred Tax Liabilities	22.07M	18.38M	18.55M	24.01M	14.08M	6.85M	10.91M	17.2M	35.55M	42.69M
Other Non-Current Liabilities	91.49M	114.98M	114.44M	90M	104.42M	90.5M	97.26M	105.47M	95.49M	109.62M
Total Liabilities	417.84M	393.79M	347.67M	507.58M	563.87M	494.94M	397.94M	400.32M	541.27M	451.9M
Total Debt+	150.23M	126.75M	78.05M	232.04M	194.02M	166.66M	125.94M	93.39M	214.77M	87.07M
Net Debt	123.89M	-71.45M	-105.42M	181.7M	46.92M	59.05M	67.27M	-13.69M	138.65M	87.07M
Debt / Equity	0.24x	0.18x	0.11x	0.30x	0.24x	0.18x	0.14x	0.10x	0.22x	0.08x
Debt / EBITDA	1.51x	1.31x	0.80x	2.54x	2.15x	1.82x	1.74x	0.94x	1.68x	0.50x
Net Debt / EBITDA	1.24x	-0.74x	-1.08x	1.99x	0.52x	0.64x	0.93x	-0.14x	1.09x	0.50x
Interest Coverage	15.36x	11.07x	11.94x	15.64x	34.42x	60.27x	56.65x	176.34x	20.74x	-
Total Equity+	629.59M	703.43M	734.46M	779.07M	798.26M	908.46M	877.51M	910.48M	983.16M	1.07B
Equity Growth %	-0.22%	11.73%	4.41%	6.07%	2.46%	13.8%	-3.41%	3.76%	7.98%	9.29%
Book Value per Share	41.40	46.22	48.20	50.72	51.94	58.93	56.81	59.21	63.03	68.68
Total Shareholders' Equity	669.61M	702.74M	733.28M	778.59M	795.18M	903M	874.28M	908.75M	980.16M	1.07B
Common Stock	152K	152K	153K	153K	153K	154K	153K	153K	154K	155K
Retained Earnings	391.93M	419.42M	516.43M	553.09M	563.02M	669.08M	656.66M	687.6M	752.19M	832.98M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	66.07M	67.5M	-2.75M	2.56M	5.06M	1.6M	-9.53M	-6.6M	-4.72M	-779K
Minority Interest	-40.02M	694K	1.18M	476K	3.08M	5.46M	3.24M	1.73M	3M	5.74M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	90.88M	94.47M	98.44M	100.1M	203.26M	62.39M	8.74M	111.22M	107.3M	185.08M
Operating CF Margin %	9.84%	9.8%	10.04%	10.05%	20.73%	6.17%	0.81%	9.74%	8.27%	12.59%
Operating CF Growth %	22.88%	3.94%	4.2%	1.69%	103.05%	-69.3%	-85.99%	1172.2%	-3.52%	72.48%
Net Income	50.54M	55.68M	58.7M	67.98M	41.99M	139.09M	19.98M	65.29M	102.09M	122.61M
Depreciation & Amortization	39.02M	42.65M	41.89M	42.42M	42.02M	40.67M	40.49M	42.03M	41.98M	44.92M
Stock-Based Compensation	509K	1.68M	1.78M	1.88M	2.45M	2.62M	2.61M	2.78M	4.16M	4.4M
Deferred Taxes	4.79M	-4.71M	718K	4.05M	-10.59M	-6.29M	6M	5.77M	17.94M	6.48M
Other Non-Cash Items	6.57M	5.89M	-653K	-20.17M	16.99M	-72.95M	13.37M	-22.05M	-33.15M	6.68M
Working Capital Changes	-10.55M	-6.72M	-4M	3.95M	110.4M	-40.74M	-73.7M	17.4M	-25.72M	0
Change in Receivables	-4.4M	-9.49M	-9.4M	4.3M	4.53M	4.09M	-3.86M	-8.56M	-26.44M	-3.68M
Change in Inventory	60K	355K	-317K	29K	-1.25M	199K	1.49M	-298K	-599K	1.24M
Change in Payables	-1.53M	-2.62M	3.47M	-856K	1.43M	-2.08M	-5.53M	2.24M	6.3M	-2.73M
Cash from Investing+	-81.48M	-9.56M	-33.66M	-14.27M	-63.88M	-65.89M	-5.98M	-17.57M	-236.69M	-33.86M
Capital Expenditures	-62.6M	-32.35M	-29.77M	-26.4M	-21.87M	-39.4M	-30.2M	-27.9M	-27.6M	-36.45M
CapEx % of Revenue	6.78%	3.36%	3.04%	2.65%	2.23%	3.9%	2.81%	2.44%	2.13%	2.48%
Acquisitions	-1.28M	-246K	3.33M	-15.81M	-203K	-29.06M	0	-7.36M	-228.1M	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-3.62M	4.08M	1.55M	-4.08M	2.06M	8.84M	8.05M	-201K	2.09M	-3.95M
Cash from Financing+	-27.13M	-49.07M	-77.27M	-79.75M	-41.89M	-35.26M	-47.64M	-42.55M	100.34M	-135.96M
Debt Issued (Net)	-3.28M	-23.48M	-48.7M	-48.92M	-14.17M	-4.42M	-4.7M	-4.99M	136.14M	0
Equity Issued (Net)	1000K	1000K	1000K	1000K	1000K	1000K	-1000K	-1000K	766K	0
Dividends Paid	-25.8M	-28.24M	-29.83M	-31.21M	-31.92M	-32.03M	-34.6M	-35.56M	-36.96M	-38.7M
Share Repurchases	-8.2M	0	-867K	-872K	-53K	-836K	-9.9M	-2.48M	-13.5M	-14.73M
Other Financing	-635K	120K	-749K	-1.09M	2.5M	-1.42M	-554K	169K	402K	-97.25M
Net Change in Cash	-17.73M	35.83M	-12.5M	6.09M	97.49M	-38.76M	-44.88M	51.1M	-29.05M	15.27M
Free Cash Flow+	28.28M	62.12M	68.66M	73.7M	181.39M	23M	-21.46M	83.31M	79.7M	148.63M
FCF Margin %	3.06%	6.44%	7%	7.4%	18.5%	2.27%	-2%	7.3%	6.14%	10.11%
FCF Growth %	81.91%	119.65%	10.53%	7.34%	146.1%	-87.32%	-193.32%	488.27%	-4.34%	86.48%
FCF per Share	1.86	4.08	4.51	4.80	11.80	1.49	-1.39	5.42	5.11	9.50
FCF Conversion (FCF/Net Income)	1.80x	1.68x	1.67x	1.47x	4.85x	0.45x	0.39x	1.66x	1.05x	1.54x
Interest Paid	4.53M	5.18M	4.9M	3.12M	1.43M	845K	493K	290K	3.42M	0
Taxes Paid	27.67M	23.55M	9.18M	20.89M	16.52M	22.88M	8.77M	14.57M	17.52M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	8.02%	8.43%	8.2%	9.01%	5.31%	16.24%	2.51%	7.47%	10.77%	11.67%
Return on Invested Capital (ROIC)	6.06%	5.86%	6.67%	4.63%	4%	4.21%	2.5%	4.65%	6.37%	8.43%
Gross Margin	40.66%	40.65%	40.56%	40.5%	37.87%	34.11%	36.13%	37.6%	37.52%	37.33%
Net Margin	5.47%	5.83%	6.01%	6.85%	4.27%	13.71%	2.09%	5.85%	7.85%	8.17%
Debt / Equity	0.24x	0.18x	0.11x	0.30x	0.24x	0.18x	0.14x	0.10x	0.22x	0.08x
Interest Coverage	15.36x	11.07x	11.94x	15.64x	34.42x	60.27x	56.65x	176.34x	20.74x	-
FCF Conversion	1.80x	1.68x	1.67x	1.47x	4.85x	0.45x	0.39x	1.66x	1.05x	1.54x
Revenue Growth	1.87%	4.37%	1.71%	1.64%	-1.57%	3.08%	6.27%	6.26%	13.7%	13.23%

National HealthCare Corporation (NHC) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare NHC vs Peers

vs ENSG

vs EHC

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

National HealthCare Corporation (NHC) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare NHC vs Peers

vs ENSG

vs EHC

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios